Directorate Change

Schroder Oriental Income Fund Ltd
03 August 2023
 

 

 

Schroder Oriental Income Fund Limited

 

Directorate Change

 

Schroder Oriental Income Fund Limited (the "Company") notes the announcement today that International Biotechnology Trust plc ("IBT") has decided to appoint Schroder Unit Trusts Limited ("Schroders"), the Company's Alternative Investment Fund Manager ("AIFM") as its AIFM.  As a result of this appointment, Kate Cornish-Bowden has advised the Board that she will resign as a director of the Company prior to Schroders' appointment as IBT's AIFM, which is expected in November 2023, in order that she continues to be deemed an independent director of IBT.

 

The Board is commencing the process of appointing a successor.

 

Paul Meader, Chairman of the Company, said:

 

"On behalf of my fellow Directors, I would like to thank Kate for her significant contribution as a non-executive director over the past five years.  We are really sorry to lose her expertise, wisdom and good humour earlier than planned.  We wish her well."

 

 

 

Enquiries:                                                                 

 

Matthew Riley

Schroder Investment Management Limited                                                          Tel: 020 7658 6596

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings